Results of Operations and Financial Condition.
On
Item 2.05
Costs Associated with Exit or Disposal Activities.
On
The Company intends to file an amended Current Report on Form 8-K when it is able to estimate the total amount or range of amounts expected to be incurred in connection with the discontinuation of the ONA-XR program, both in the aggregate and for each major type of cost, and an estimate of the amount or range of amounts of the charge that will result in future cash expenditures, if any.
Item 7.01. Regulation FD Disclosure.
On
* * *
The information in this Item 2.02, Item 7.01, Exhibit 99.1 and Exhibit 99.2 attached hereto are being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.
Item 9.01. Exhibits. (d) Exhibits Exhibit No. Description Press Release issued byContext Therapeutics Inc. , dated 99.1March 22, 2023 Context Therapeutics Inc. Corporate Presentation - March 99.2 2023 Cover Page Interactive Data File (embedded within the inline 104 XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source